Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach-Reference-Cited by-同舟云学术

Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach

Published:2020-03-02 Issue:10 Volume:47 Page:2313-2321
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Olthof Susann-Cathrin^ORCID,Forschner Andrea^ORCID,Martus Peter^ORCID,Garbe Claus^ORCID,Nikolaou Konstantin^ORCID,la Fougère Christian^ORCID,Gückel Brigitte^ORCID,Vach Werner^ORCID,Pfannenberg Christina^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-020-04733-x.pdf

Reference26 articles.

1. Svedman FC, et al. Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. Clin Epidemiol. 2016;8:109–22.

2. Gwadry-Sridhar F, et al. Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study. Curr Oncol. 2017;24(3):168–75.

3. Serra-Arbeloa P, et al. Cost of cutaneous melanoma by tumor stage: a descriptive analysis. Actas Dermosifiliogr. 2017;108(3):229–36.

4. Pfannenberg C, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007;43(3):557–64.

5. Pfannenberg C, Schwenzer N. Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI. Radiologe. 2015;55(2):120–6.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How [18F]-FDG-PET/CT Affects Clinical Management of Patients with Germ Cell Tumors in the Real World;Cancers;2023-07-17

2. PET Imaging of Melanoma;Nuclear Medicine and Molecular Imaging;2022

3. PET/CT bei Patienten mit Melanom: eine Zweiklassenversorgung? Stand der Versorgung mit PET/CT in der primären Ausbreitungsdiagnostik des Melanoms;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-06

4. PET/CT in malignant melanoma: a two‐tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CT;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-04-22

5. Patienten mit fortgeschrittenen malignen Melanomen profitieren eindeutig von der 18F-FDG-PET/CT;Der Nuklearmediziner;2021-03